Data Updates in GI Cancers and HCC from ESMO 2024 - Episode 3
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on data for neoadjuvant nivolumab plus ipilimumab in dMMR colon cancer.
Related Content: